ARB

Implantica publishes Interim Report January - September 2023 (Q3)

Retrieved on: 
Mittwoch, November 22, 2023
ID, Mary, mother of Jesus, Corporate Affairs, Safety, Food, CFO, Saint Mary's Hospital, GERD, Investment, EFS, Surgeon, Nissen fundoplication, Learning, Vienna General Hospital, Patient, CET, Congress, FDA, ARB, NHS, AFS, Food and Drug Administration, Usability, IPAC, Certification, ISPOR, Health, Hospital, PMA, Hernia, Pharmaceutical industry, Medical device

The Interventional Procedures Advisory Committee (IPAC) has now started its review of the safety and efficacy of RefluxStop™.

Key Points: 
  • The Interventional Procedures Advisory Committee (IPAC) has now started its review of the safety and efficacy of RefluxStop™.
  • The IPAC review process is a key step for NHS hospitals to adopt our technology with strong international influence.
  • Implantica will hold a teleconference on 22 November 2023 at 15:00 (CET) with Peter Forsell (CEO), Andreas Öhrnberg (CFO), and Nicole Pehrsson (Chief Corporate Affairs Officer).
  • The information was submitted for publication, through the agency of the contact person set out above, at 2023-11-22 08:00 CET.

Implantica's RefluxStop™ makes an impact at the leading Annual European Foregut Society Meeting

Retrieved on: 
Mittwoch, November 15, 2023
Associate, EFS, GERD, Surgeon, Teaching hospital, Patient, CET, ARB, Scientific programming language, Humble, Texas, GI, Certification, Congress, Quality of life, Deutsche Medizinische Wochenschrift, Health

), a medtech company at the forefront of bringing advanced technology into the body, announces participation in the 3rd Annual EFS (European Foregut Society) Congress in Milan, Italy in early November.

Key Points: 
  • ), a medtech company at the forefront of bringing advanced technology into the body, announces participation in the 3rd Annual EFS (European Foregut Society) Congress in Milan, Italy in early November.
  • The Scientific Program at EFS included the symposium, 'Reconstruction of the Anti-Reflux Barrier (ARB) with RefluxStop™- an innovative approach.'
  • This well-attended event, filled with lively conversation, offered an opportunity to learn directly from experts with real-world experience performing the RefluxStop™ procedure.
  • Dr. Forsell goes on to say, "The 3rd Annual EFS Meeting gave Implantica the opportunity to spotlight RefluxStop™ and report on the excellent clinical data.

Authentic Restaurant Brands Completes Acquisition of Fiesta Restaurant Group

Retrieved on: 
Montag, Oktober 30, 2023
Finance, Restaurant, Bar, Food, Beverage, Retail, Professional Services, Knowledge, Fiesta Restaurant Group, Acquisition, Restaurant Brands, ARB, Love, Fiesta, Pollo Tropical

Authentic Restaurant Brands (“ARB”), a portfolio company of Garnett Station Partners, LLC (“Garnett Station” or “GSP”), a New York-based principal investment firm, today announced the completion of its previously announced acquisition of Fiesta Restaurant Group, Inc. ("Fiesta" or the "Company") (NASDAQ: FRGI), parent company of the Pollo Tropical® restaurant brand.

Key Points: 
  • Authentic Restaurant Brands (“ARB”), a portfolio company of Garnett Station Partners, LLC (“Garnett Station” or “GSP”), a New York-based principal investment firm, today announced the completion of its previously announced acquisition of Fiesta Restaurant Group, Inc. ("Fiesta" or the "Company") (NASDAQ: FRGI), parent company of the Pollo Tropical® restaurant brand.
  • “Our distinct vision for Pollo Tropical is to amplify the fundamental aspects of the brand that customers love and expand its capabilities to deliver high-quality, affordable food in a casual setting,” said Alex Macedo, Chairman of Authentic Restaurant Brands.
  • The consideration paid to Fiesta common stockholders as part of the transaction is $8.50 per share in cash.
  • Stockholders approved the merger agreement proposal at a special meeting of Fiesta stockholders on October 24, 2023, in connection with the previously announced definitive agreement between the Company and ARB.

Human Biome Announces Prediction of first-in class, Biosynthetic Microbiome Against Silent Pandemic of Antibiotic-Resistant Bacteria and Doses First Patients in Contextual FMT Study to validate it

Retrieved on: 
Dienstag, Oktober 31, 2023
NGB, Drug discovery, Doctor of Philosophy, Death, HBI, CDC, ARB, Microbiota, Biobank, Public, FMT, Cancer, Patient, Platform, Antibiotics

WARSAW, Poland, Oct. 31, 2023 /PRNewswire/ -- This is a major milestone for Human Biome, the field of microbiome medicine and whole epidemiology.

Key Points: 
  • WARSAW, Poland, Oct. 31, 2023 /PRNewswire/ -- This is a major milestone for Human Biome, the field of microbiome medicine and whole epidemiology.
  • Antibiotic resistance is a growing threat to public health, and new treatments are urgently needed.
  • The New-Generation Biotherapeutic (NGB) drug candidate has the potential to provide a new paradigm in preventing antibiotic-resistant bacteria (ARB) infections.
  • Now, we have predicted fully synthetic microbiome drug composition and our AI-based analysis confirms its efficacy – commented CEO and R&D Director of Human Biome Jaroslaw Bilinski MD, PhD.

Human Biome Announces Prediction of first-in class, Biosynthetic Microbiome Against Silent Pandemic of Antibiotic-Resistant Bacteria and Doses First Patients in Contextual FMT Study to validate it

Retrieved on: 
Dienstag, Oktober 31, 2023
NGB, Drug discovery, Doctor of Philosophy, Death, HBI, CDC, ARB, Microbiota, Biobank, Public, FMT, Cancer, Patient, Platform, Antibiotics

WARSAW, Poland, Oct. 31, 2023 /PRNewswire/ -- This is a major milestone for Human Biome, the field of microbiome medicine and whole epidemiology.

Key Points: 
  • WARSAW, Poland, Oct. 31, 2023 /PRNewswire/ -- This is a major milestone for Human Biome, the field of microbiome medicine and whole epidemiology.
  • Antibiotic resistance is a growing threat to public health, and new treatments are urgently needed.
  • The New-Generation Biotherapeutic (NGB) drug candidate has the potential to provide a new paradigm in preventing antibiotic-resistant bacteria (ARB) infections.
  • Now, we have predicted fully synthetic microbiome drug composition and our AI-based analysis confirms its efficacy – commented CEO and R&D Director of Human Biome Jaroslaw Bilinski MD, PhD.

EQS-News: BingX Releases Comprehensive Update of 4th Quarter 2023 Crypto Analysis and Highlights STORJ

Retrieved on: 
Freitag, Oktober 27, 2023
Crypto, Bitcoin, AAVE, Decentralized finance, BTC, MIT EAD Airframe Version 2, ETF, ANT, ARB, Cryptocurrency

SINGAPORE - Media OutReach - 27 October 2023 - BingX, a leading cryptocurrency exchange, is excited to announce the release of the highly anticipated Version 2 of its 4th Quarter 2023 Crypto Report.

Key Points: 
  • SINGAPORE - Media OutReach - 27 October 2023 - BingX, a leading cryptocurrency exchange, is excited to announce the release of the highly anticipated Version 2 of its 4th Quarter 2023 Crypto Report.
  • This updated report offers an in-depth examination of cryptocurrency price analysis and spotlights high value projects, building upon the success of its predecessor.
  • Version 2 of the 4th Quarter 2023 Crypto Report by BingX provides detailed insights and updates into cryptocurrency market performance and uncovers some of the most promising projects in crypto space.
  • BingX's Version 2 of the 4th Quarter 2023 Crypto Report builds on the success of its previous edition of Token Price Analysis V1 , offering fresh insights into the dynamic cryptocurrency market.

Equation Announces its Highly Anticipated Mainnet Launch on Arbitrum

Retrieved on: 
Freitag, Oktober 27, 2023
Maker, Decentralized finance, 2000s, RBF, EFC, Connector, ETH, Interactivity, SOL, USDC, History, MATIC, Equation, Uniswap, Non-fungible token, LP record, OP, Risk, Ecosystem, Liquidity, AVAX, Next Generation, ARB, LINK, Tokenomics, BTC, Safety, NFT, Cryptocurrency

SINGAPORE, Oct. 27, 2023 (GLOBE NEWSWIRE) -- Equation, the perpetual contract protocol in the world of Decentralized Finance (DeFi), is set to make a significant leap as it announces its official launch on the Arbitrum Mainnet, scheduled for October 28th at 0:00 UTC.

Key Points: 
  • SINGAPORE, Oct. 27, 2023 (GLOBE NEWSWIRE) -- Equation, the perpetual contract protocol in the world of Decentralized Finance (DeFi), is set to make a significant leap as it announces its official launch on the Arbitrum Mainnet, scheduled for October 28th at 0:00 UTC.
  • The team behind Equation is committed to pushing the boundaries of DeFi, and the launch on the Arbitrum Mainnet represents a pivotal moment in the project's roadmap.
  • Equation is positioning itself as "The Next Generation of Decentralized Perpetual Exchange", offering both traders and liquidity providers with up to 200x leverage.
  • Upon the Mainnet Launch, Equation will support perpetual trading for various currencies, including ETH, BTC, SOL, ARB, OP, MATIC, AVAX, and LINK.

The Emission Control Catalysts Market to grow by USD 4.24 billion from 2022 to 2027 | Environmental concerns and measures to curb pollution to drive the growth- Technavio

Retrieved on: 
Montag, September 25, 2023
Ashland Global, Honeywell, Johnson Matthey, ARB, California Air Resources Board, Control, Diesel exhaust, LEED, Oxygen, SCR, Refrigeration, YOY, USD, Hydrochloric acid, Fluid, Solvay S.A., Toyota, NOx, Nature, Ammonia, Water, Automatic, Biophysical environment, BASF SE, Ozone, Growth, SE, Nitric acid, BASF, Cummins, Environment, Renewable energy, Beauty salon, Palladium, Application, Geography, Rhodium, Platinum

NEW YORK, Sept. 25, 2023 /PRNewswire/ -- The emission control catalysts market is expected to grow by USD 4.24 billion between 2022 and 2027.

Key Points: 
  • NEW YORK, Sept. 25, 2023 /PRNewswire/ -- The emission control catalysts market is expected to grow by USD 4.24 billion between 2022 and 2027.
  • Environmental concerns and measures to curb pollution are key factors driving market growth.
  • Environmental and health pollution caused by the exhaust of vehicles has a significant impact, resulting in ozone depletion and greenhouse gas emissions.
  • Environmentally friendly solutions for stationary and mobile emission sources worldwide are expected to be supported by advanced equipment and sustainable systems.

Your Crypto Airdrop Can Now Be Seen By Millions of Readers on U.Today

Retrieved on: 
Mittwoch, September 20, 2023
Crypto, Blockchain, NFT, ARB, Decentralized finance, Premium, Economics, Social media, Standard, Participation, Cryptocurrency, Feature

So far, this is the most impressive traffic accomplishment for the reputable crypto website.

Key Points: 
  • So far, this is the most impressive traffic accomplishment for the reputable crypto website.
  • With this milestone reached, U.Today proudly offers new services for teams that organize airdrops for their crypto tokens.
  • Adding a crypto airdrop to the U.Today Crypto Airdrops Portal will guarantee an inflow of motivated and passionate leads to every segment of Web3 economics.
  • Your airdrop will be listed together with the most hyped crypto airdrop campaigns of 2023, including Arbitrum's ARB, SupraOracles' SUPRA, CyberConnect's CYBER and so on.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Earthstone Energy, Inc. (NYSE - ESTE), Fiesta Restaurant Group, Inc. (Nasdaq - FRGI), Veritiv Corporation (NYSE - VRTV)

Retrieved on: 
Donnerstag, September 14, 2023
Permian, CD, ARB, Tripura Merger Agreement, Brodsky, CD&R, Clayton, Dubilier & Rice, NYSE, Dubilier, Security (finance), Veritiv, Fiesta

BALA CYNWYD, Pa., Sept. 14, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations.

Key Points: 
  • BALA CYNWYD, Pa., Sept. 14, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations.
  • If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
  • Under the terms of the Merger Agreement, Earthstone Energy will be acquired by Permian Resources Corporation (“Permian Resources”) (NYSE - PR).
  • Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits.